You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.
This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.
This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.
With mySugr® and Accu-Chek® Smart Pix by Roche, data from NovoPen® 6 or NovoPen Echo® Plus can be viewed alongside glucose data for quick and easy pattern and trend identification.
You can learn more about the smart insulin integration in mySugr® and
Accu-Chek® Smart Pix in Roche's Diabetes Care Showroom
{{numberOfResults}} {{resultString}}
Accu-Chek® Smart Pix, the mySugr® app, and the RocheDiabetes Care Platform are registered products of Roche. The solutions are part of Roche Diabetes Care’s suite of diabetes management offerings and integrate with Novo Nordisk connected devices. The solutions and brands displayed are property of Roche.
NovoPen® 6 and NovoPen Echo® Plus are medical devices that comply with current legislation. No contraindications or adverse effects are anticipated with this product.
NovoPen® 6 and NovoPen Echo® Plus are available in a number of countries and additional launches are planned for 2023. Launches for 2023 vary according to device, insulin brand and unique market regulations.
NovoPen® 6 & NovoPen Echo® Plus Design Specification / Verification Report (Data on File).
Klonoff DC et al. JDiabetes SciTechnol. 2018;12(3):551-553.
Peter Adolfsson et al. Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen. DIABETES TECHNOLOGY & THERAPEUTICS Volume 22, Number 10, 2020
Ashrafzadeh S, Hamdy O. Patient-driven diabetes care of the future in the technology era. Cell Metabolism. 2019; 29(3): 564-575.